Patent details

Basic Information

Publication number:

EP3624831

PCT Application Number:

US2018032815

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP188027221

PCT Publication Number:

WO2018213340

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

RECOMBINANT HUMAN ACID ALPHA-GLUCOSIDASE

French Title of Invention:

ALPHA-GLUCOSIDASE D'ACIDE HUMAIN RECOMBINANT

German Title of Invention:

REKOMBINANTE MENSCHLICHE SAURE ALPHA-GLUCOSIDASE

SPC Number:

Dates

Filing date:

15/05/2018

Grant date:

29/03/2023

EP Publication Date:

25/03/2020

PCT Publication Date:

22/11/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/03/2023

EP B1 Publication Date:

29/03/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

15/05/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/03/2023

 

 

Name:

Amicus Therapeutics, Inc.

Address:

3675 Market Street, Philadelphia, PA 19104, United States (US)

Agent

Name:

ARONOVA S.A.

From:

14/06/2023

Address:

PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

Inventor

1

Name:

DO, Hung

Address:

United States (US)

2

Name:

SUNDERLAND, Wendy

Address:

United States (US)

3

Name:

LUN, Yi

Address:

United States (US)

4

Name:

CHAR, Hing

Address:

United States (US)

5

Name:

KHANNA, Richie

Address:

United States (US)

6

Name:

GOTSCHALL, Russell

Address:

United States (US)

7

Name:

DILONÉ, Enrique

Address:

United States (US)

8

Name:

TESLER, Sergey

Address:

United States (US)

Priority

1

Priority Number:

201762506561 P

Priority Date:

15/05/2017

Priority Country:

United States (US)

2

Priority Number:

201762506574 P

Priority Date:

15/05/2017

Priority Country:

United States (US)

3

Priority Number:

201762506569 P

Priority Date:

15/05/2017

Priority Country:

United States (US)

4

Priority Number:

201762529300 P

Priority Date:

06/07/2017

Priority Country:

United States (US)

5

Priority Number:

201762564083 P

Priority Date:

27/09/2017

Priority Country:

United States (US)

6

Priority Number:

201762567334 P

Priority Date:

03/10/2017

Priority Country:

United States (US)

7

Priority Number:

201862618021 P

Priority Date:

16/01/2018

Priority Country:

United States (US)

8

Priority Number:

201862624638 P

Priority Date:

31/01/2018

Priority Country:

United States (US)

9

Priority Number:

201862660758 P

Priority Date:

20/04/2018

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/43; A61P 21/00; A61P 25/00; A61P 43/00; A61K 38/47;

Publication

European Patent Bulletin

1

Issue number:

202313

Publication date:

29/03/2023

Description:

Grant (B1)

2

Issue number:

202318

Publication date:

03/05/2023

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

01/06/2026

Annual Fee Number:

9

Annual Fee Amount:

115 Euro

Expected Payer:

Last Annual Fee Payment Date:

29/04/2025

Last Annual Fee Paid Number:

8

Last Annual Fee Paid Amount:

99 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
14/06/2023	Power Of Attorney	1
15/06/2023	Outgoing Correspondence	1